publication date: Mar. 18, 2016
Clearly, Lisa Rosenbaum wanted to trigger a heated discussion—but not of the sort she ended up with.
Rosenbaum, a national correspondent at the New England Journal of Medicine, focused on the demise of power morcellation, a once widely used gynecological procedure, which in some cases ended up disseminating undetected uterine sarcomas.
In a paper published in the March 10 issue of the journal and titled “N-of-1 Policymaking—Tragedy, Trade-offs, and the Demise of Morcellation,” Rosenbaum alleges that Amy Reed, a high-profile opponent of power morcellation, had stage IV cancer before her hysterectomy.
Senate Bill Gives FDA More Control Over Its Hiring, Salaries and Structure
The FDA and NIH Workforce Authorities Modernization Act was introduced in the Senate by Republican and Democratic leaders of the health committee. The bill aims to help FDA and NIH “attract top talent during this exciting time in science.”
The bill, introduced by Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), looks to improve coordination within and between FDA medical product centers and allow the FDA to update its structure, as well as make it easier for the agency to hire; improve access to scientific meetings for federal employees; and streamline processes for NIH research information collection.
Slamming the Door
Part VIII – A Conversation with DePinho
The $18 million never made it from Austin to Houston.
MD Anderson’s initial stance was to deflect all CPRIT-related questions to CPRIT, but this didn’t make the controversy go away. So, the cancer center suggested that the grant undergo scientific review, as well as commercial.
Recently, I asked Dan Fontaine, MD Anderson’s executive chief of staff why the money never changed hands.
Bunn Wins ASCO Karnofsky Award; Kaelin to Receive Science of Oncology Award
The American Society of Clinical Oncology announced the winners of its highest honors, the Special Awards, to be presented during the 2016 ASCO Annual Meeting in June.
“The exceptional accomplishments of each of our awardees reflect their exemplary dedication to furthering cancer research and serving as a beacon of hope to the cancer community,” said Peter Paul Yu, immediate past president of ASCO and chair of the Special Awards Selection Committee. “It is our honor to recognize their enduring contributions with ASCO’s most prestigious awards.”
UNMC Radiologist Glenn Dalrymple, 81;
and MSKCC Researcher Robert Golbey, 93
Glenn Dalrymple, a radiology professor at the University of Nebraska Medical Center from 1990 to 1996, died March 9 in Omaha after a long battle with colon cancer. He was 81.
Itai Yanai to Lead New Institute at NYU Langone
Debra Patt named Editor-in-Chief of JCO Clinical Cancer Informatics
Jennie Crews elected president of Association of Community Cancer Centers
- Charles Serhan receives Ross Prize from Feinstein Institute for Medical Research
American Society of Clinical Oncology publishes State of Cancer Care 2016
V Foundation and WWE announce research funding partnership
Providence Health & Services and Institute for Systems Biology
|Drugs and Targets|
Gilead Halts 6 Zydelig Trials As FDA, EMA Warn of Deaths From Respiratory Infections
FDA Grants Orphan Designation to VAL-083
FDA Grants Priority Review to Atezolizumab